Pulse Biosciences, Inc. (PLSE)
44.43
-1.16
(-2.54%)
USD |
NASDAQ |
Oct 16, 16:00
44.39
-0.04
(-0.09%)
After-Hours: 20:00
Pulse Biosciences Free Cash Flow : -61.39M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.39M |
| March 31, 2026 | -55.52M |
| December 31, 2025 | -54.46M |
| September 30, 2025 | -48.79M |
| June 30, 2025 | -44.76M |
| March 31, 2025 | -40.25M |
| December 31, 2024 | -36.47M |
| September 30, 2024 | -34.09M |
| June 30, 2024 | -35.54M |
| March 31, 2024 | -36.34M |
| December 31, 2023 | -33.16M |
| September 30, 2023 | -34.35M |
| June 30, 2023 | -34.53M |
| March 31, 2023 | -38.15M |
| December 31, 2022 | -47.41M |
| September 30, 2022 | -52.24M |
| June 30, 2022 | -55.05M |
| March 31, 2022 | -58.67M |
| December 31, 2021 | -54.53M |
| September 30, 2021 | -51.24M |
| Date | Value |
|---|---|
| June 30, 2021 | -46.34M |
| March 31, 2021 | -37.75M |
| December 31, 2020 | -35.81M |
| September 30, 2020 | -35.43M |
| June 30, 2020 | -35.32M |
| March 31, 2020 | -37.21M |
| December 31, 2019 | -34.79M |
| September 30, 2019 | -31.98M |
| June 30, 2019 | -30.40M |
| March 31, 2019 | -26.50M |
| December 31, 2018 | -24.17M |
| September 30, 2018 | -21.94M |
| June 30, 2018 | -18.38M |
| March 31, 2018 | -16.19M |
| December 31, 2017 | -13.64M |
| September 30, 2017 | -11.85M |
| June 30, 2017 | -10.47M |
| March 31, 2017 | -9.113M |
| December 31, 2016 | -8.115M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Accuray, Inc. | -19.26M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -26.93M |
| ResMed, Inc. | 1.629B |
| Rockwell Medical, Inc. | 1.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.71M |
| Cash from Investing (Quarterly) | -0.09M |
| Cash from Financing (Quarterly) | 52.10M |
| Free Cash Flow Per Share (Quarterly) | -0.2717 |
| Free Cash Flow to Equity (Quarterly) | -18.42M |
| Free Cash Flow to Firm (Quarterly) | -18.80M |
| Free Cash Flow Yield | -2.03% |